Cargando…
New and developing therapies for atopic dermatitis
Atopic dermatitis is a common inflammatory skin disease. New understanding in disease pathogenesis has led to a considerable number of promising new drugs in development. New topical agents can be especially helpful for children, providing an alternative to the need for chronic topical corticosteroi...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Dermatologia
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871372/ https://www.ncbi.nlm.nih.gov/pubmed/29641707 http://dx.doi.org/10.1590/abd1806-4841.20187682 |
_version_ | 1783309635876290560 |
---|---|
author | Hajar, Tamar Gontijo, João Renato Vianna Hanifin, Jon M |
author_facet | Hajar, Tamar Gontijo, João Renato Vianna Hanifin, Jon M |
author_sort | Hajar, Tamar |
collection | PubMed |
description | Atopic dermatitis is a common inflammatory skin disease. New understanding in disease pathogenesis has led to a considerable number of promising new drugs in development. New topical agents can be especially helpful for children, providing an alternative to the need for chronic topical corticosteroid use. While many patients with mild or moderate disease can be managed with topical treatments, there are unmet needs for recalcitrant and severe cases. New and developing therapies hold promise for real advances in management of this complex disease. |
format | Online Article Text |
id | pubmed-5871372 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Sociedade Brasileira de Dermatologia |
record_format | MEDLINE/PubMed |
spelling | pubmed-58713722018-03-29 New and developing therapies for atopic dermatitis Hajar, Tamar Gontijo, João Renato Vianna Hanifin, Jon M An Bras Dermatol Special Article Atopic dermatitis is a common inflammatory skin disease. New understanding in disease pathogenesis has led to a considerable number of promising new drugs in development. New topical agents can be especially helpful for children, providing an alternative to the need for chronic topical corticosteroid use. While many patients with mild or moderate disease can be managed with topical treatments, there are unmet needs for recalcitrant and severe cases. New and developing therapies hold promise for real advances in management of this complex disease. Sociedade Brasileira de Dermatologia 2018 /pmc/articles/PMC5871372/ /pubmed/29641707 http://dx.doi.org/10.1590/abd1806-4841.20187682 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivative License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium provided the original work is properly cited and the work is not changed in any way. |
spellingShingle | Special Article Hajar, Tamar Gontijo, João Renato Vianna Hanifin, Jon M New and developing therapies for atopic dermatitis |
title | New and developing therapies for atopic dermatitis |
title_full | New and developing therapies for atopic dermatitis |
title_fullStr | New and developing therapies for atopic dermatitis |
title_full_unstemmed | New and developing therapies for atopic dermatitis |
title_short | New and developing therapies for atopic dermatitis |
title_sort | new and developing therapies for atopic dermatitis |
topic | Special Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871372/ https://www.ncbi.nlm.nih.gov/pubmed/29641707 http://dx.doi.org/10.1590/abd1806-4841.20187682 |
work_keys_str_mv | AT hajartamar newanddevelopingtherapiesforatopicdermatitis AT gontijojoaorenatovianna newanddevelopingtherapiesforatopicdermatitis AT hanifinjonm newanddevelopingtherapiesforatopicdermatitis |